血管炎临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 血管炎（国际通用名 vasculitis）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖ANCA 相关性血管炎等说法。

正在招募的血管炎新药试验

• Vascular Lab Resource (VLR) Biorepository

  不适用招募中美国NCT05628948

• Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis

  II 期招募中法国NCT06940661

• Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

  不适用招募中法国NCT06599411

• European and North Indian Cohort of KaWasaki dIsease

  不适用招募中BrazilCroatia法国IndiaNCT06305611

• A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab

  II 期招募中法国NCT07268521

• Ocular Manifestations of Granulomatosis With Polyangiitis.

  不适用招募中PolandNCT07664709

• Global Initiative on Takayasu Arteritis (GITA)

  不适用招募中Turkey (Türkiye)NCT07558382

• Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

  早期 I 期招募中中国NCT07246096

• The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

  I 期招募中中国NCT06285279

• Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  III 期招募中美国ArgentinaAustriaBelgiumNCT07444567

• The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

  不适用招募中意大利NCT07275190

• A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease

  III 期招募中中国NCT06145893